Source

Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor (Text with EEA relevance.)

Implementing Regulation (EU) 2018/917 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 15, Diquat, the date is replaced by ‘30 June 2019’; (2) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date is replaced by ‘30 June 2019’; (3) in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2019’; (4) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2019’; (5) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2019’; (6) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2019’; (7) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2019’; (8) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2019’; (9) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2019’; (10) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2019’; (11) in the sixth column, expiration of approval, of row 78, Chlorpropham, the date is replaced by ‘31 July 2019’; (12) in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2019’; (13) in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2019’; (14) in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2019’; (15) in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2019’; (16) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2019’; (17) in the sixth column, expiration of approval, of row 96, Methoxyfenozide, the date is replaced by ‘31 July 2019’; (18) in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2019’; (19) in the sixth column, expiration of approval, of row 98, Gliocladium catenulatum strain: J1446, the date is replaced by ‘31 July 2019’; (20) in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2019’; (21) in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2019’; (22) in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2019’; (23) in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2019’; (24) in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2019’; (25) in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2019’; (26) in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2019’; (27) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2019’; (28) in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2019’; (29) in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2019’; (30) in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2019’; (31) in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2019’; (32) in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2019’; (33) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2019’; (34) in the sixth column, expiration of approval, of row 155, ethoprophos, the date is replaced by ‘31 July 2019’; (35) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2019’; (36) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2019’; (37) in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2019’; (38) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2019’; (39) in the sixth column, expiration of approval, of row 165, Carvone, the date is replaced by ‘31 July 2019’; (40) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2019’; (41) in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2019’; (42) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2019’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview